[1]. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020 Apr 30; 382[18]:1708-20. DOI:10.1056/NEJMoa2002032
[2]. Fan W, Su Z, Bin Y, Yan-Mei C, Wen W, Zhi-Gang S, Yi H, Zhao-Wu T, Jun-Hua T, Yuan-Yuan P, Ming-Li Y. Holmes Edward C., Zhang Yong-Zhen. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579[7798]:265-9. doi.org/10.1038/s41586020-2008-3
[3]. Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M. Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. 2020 Feb 27.doi.org/10.1016/j.apsb.2020.02.008
[4]. Tavakoli A, Vahdat K, Keshavarz M. Novel coronavirus disease 2019 [COVID-19]: an emerging infectious disease in the 21st century. ISMJ. 2020 Jan 10; 22[6]:432-50. DOI: 10.29252/ismj.22.6.432
[5]. Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, Meng J, Zhu Z, Zhang Z, Wang J, Sheng J. Genome composition and divergence of the novel coronavirus [2019-nCoV] originating in China. Cell host & microbe. 2020 Feb 7.DOI: 10.1016/j.chom.2020.02.001
[6]. Yang X, Yu Y, Xu J, Shu H, Liu H, Wu Y, Zhang L, Yu Z, Fang M, Yu T, Wang Y. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine. 2020 Feb 24.DOI: 10.1016/S0140-6736[20]30183-5
[7]. Kazeminia M, Jalali R, Vaisi-Raygani A, Khaledi-Paveh B, Salari N, Mohammadi M, Sabbaghchi M. Fever and Cough are Two Important Factors in Identifying Patients with the Covid-19: A Meta-Analysis. Journal of Military Medicine. 2020 Feb 1;22[2]:193-202.DOI:10.30491/JMM.22.2.193
[8]. Karimi M, Bolandian M, Mirzaei Nodoushan M. A Review on the Mechanisms Involved in the Immunopathogenesis of SARS-CoV-2. Journal Mil Med. 2020 Apr 10;22[2]:14760.DOI: 10.30491/JMM.22.2.147
[9]. Prompetchara E, Ketloy C, Palaga T. Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol. 2020 Mar 1;38[1]:1-9.DOI: 10.12932/AP-200220-0772
[10]. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395:507-13. doi.org/10.1016/S0140-6736[20]30211-7
[11]. World Health Organization. Coronavirus disease 2019 [COVID-19]: situation report, 82.
[12]. Gorse GJ, Patel GB, Vitale JN, O'Connor TZ. Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum. Clinical and Vaccine Immunology. 2010 Dec 1;17[12]:187580.doi:10.1128/CVI.00278-10.
[13]. Arabi YM, Balkhy HH, Hayden FG, Bouchama A, Luke T, Baillie JK, Al-Omari A, Hajeer AH, Senga M, Denison MR, Nguyen-Van-Tam JS. Middle East respiratory syndrome. New England Journal of Medicine. 2017 Feb 9;376[6]:58494.DOI: 10.1056/nejmsr1408795
[14]. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020 Mar 11.doi.org/10.1016/S0140-6736[20]30566-3
[15]. Zhu N, Zhang D, Wang W. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019 [published January 24, 2020]. N Engl J Med.DOI: 10.1056/NEJMoa2001017
[16]. Dandekar AA, Perlman S. Immunopathogenesis of coronavirus infections: implications for SARS. Nature reviews immunology. 2005 Dec;5[12]:917-27.doi: 10.1038/nri1732
[17]. De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology. 2016 Aug;14[8]:523.DOI: 10.1038/nrmicro.2016.81 .
18]. Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. InSeminars in immunopathology 2017 Jul [Vol. 39, No. 5, pp. 529-539]. Springer Berlin Heidelberg.DOI: 10.1007/s00281-017-0629x
[19]. Kindler E, Thiel V, Weber F. Interaction of SARS and MERS coronaviruses with the antiviral interferon response. InAdvances in virus research 2016 Jan 1 [Vol. 96, pp. 219243]. Academic Press. doi: 10.1016/bs.aivir.2016.08.006
[20]. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, Wang W, Song H, Huang B, Zhu N, Bi Y. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet. 2020 Feb 22; 395[10224]:565-74.Doi: 10.1016/S0140-6736[20]30251-8.
[21]. Liu WJ, Zhao M, Liu K, Xu K, Wong G, Tan W, Gao GF. Tcell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV. Antiviral research. 2017 Jan 1; 137:82-92. DOI: 10.1016/j.antiviral.2016.11.006
[22]. Zhou P, YANG X, wANG XG, HU B. ZHANG w. Si Hr, zHu y, li B, HuanG cl, cHen HD, cHen J, luo y, Guo H, JianG rD, liu MQ, cHen y, SHen Xr, WanG X, zHenG XS, zHao K, cHen QJ, DenG F, liu ll, yan B, zHan FX, WanG yy, Xiao GF, SHi zl. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579:270-3. Available from: https://doi.org/10.1038/s41586-020-2012-7
[23]. Li CK, Wu H, Yan H, Ma S, Wang L, Zhang M, Tang X, Temperton NJ, Weiss RA, Brenchley JM, Douek DC. T cell responses to whole SARS coronavirus in humans. The Journal of Immunology. 2008 Oct 15; 181[8]:5490-500. DOI: https://doi.org/10.4049/jimmunol.181.8.5490
[24]. Shin HS, Kim Y, Kim G, Lee JY, Jeong I, Joh JS, Kim H, Chang E, Sim SY, Park JS, Lim DG. Immune responses to Middle East respiratory syndrome coronavirus during the acute and convalescent phases of human infection. Clinical Infectious Diseases. 2019 Mar 5;68[6]:984-92.DOI: 10.1093/cid/ciy595
[25]. Li Z, Yi Y, Luo X, Xiong N, Liu Y, Li S, Sun R, Wang Y, Hu B, Chen W, Zhang Y. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARSCoV‐2 infection diagnosis. Journal of medical virology. 2020 Feb 27.
[26]. Thevarajan I, Nguyen TH, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B, Tong SY. Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nature medicine. 2020 Apr;26[4]:453-5.doi: 10.1038/s41591-020-0819-2
[27]. Cristina S, Concetta R, Francesco R, Annalisa C. SARSCov-2 infection: Response of human immune system and possible implications for the rapid test and treatment. International Immunopharmacology. 2020 Apr 16:106519.